final 2
final 2



Product Details:



ZETACOLEST tablets, for oral use, contain :

The active substance is bempedoic acid. Each film-coated tablet contains 180 mg of bempedoic acid.


Indications and usage:

ZETACOLEST is indicated:

• To reduce the risk of myocardial infarction and coronary revascularization in adults who are

unable to take recommended statin therapy (including those not taking a statin) with:

 established cardiovascular disease (CVD), or

 a high risk for a CVD event but without established CVD.

• As an adjunct to diet, in combination with other low-density lipoprotein cholesterol (LDL-C)

lowering therapies, or alone when concomitant LDL-C lowering therapy is not possible, to

reduce LDL-C in adults with primary hyperlipidemia, including heterozygous familial

hypercholesterolemia (HeFH).


Storage and handling :

Carton Box containing 1,2 or 3 Strips (AL\AL), each of 10 Film Coated Tablets and inner leaflet.